| Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells P Chowdhury, PKB Nagesh, E Hatami, S Wagh, N Dan, MK Tripathi, ... Journal of colloid and interface science 535, 133-148, 2019 | 126 | 2019 |
| Reverse translation of US Food and Drug Administration reviews of oncology new molecular entities approved in 2011–2017: lessons learned for anticancer drug development S Faucette, S Wagh, A Trivedi, K Venkatakrishnan, N Gupta Clinical and Translational Science 11 (2), 123-146, 2018 | 35 | 2018 |
| Cross-linked polyphenol-based drug nano-self-assemblies engineered to blockade prostate cancer senescence PKB Nagesh, P Chowdhury, E Hatami, S Kumari, VK Kashyap, ... ACS applied materials & interfaces 11 (42), 38537-38554, 2019 | 34 | 2019 |
| Electrophilicity of pyridazine-3-carbonitrile, pyrimidine-2-carbonitrile, and pyridine-carbonitrile derivatives: a chemical model to describe the formation of thiazoline … S Sinha, D Ahire, S Wagh, D Mullick, R Sistla, K Selvakumar, JC Cortes, ... Chemical Research in Toxicology 27 (12), 2052-2061, 2014 | 20 | 2014 |
| Practical and economical implementation of online H/D exchange in LC-MS RP Shah, A Garg, SP Putlur, S Wagh, V Kumar, V Rao, S Singh, ... Analytical chemistry 85 (22), 10904-10912, 2013 | 18 | 2013 |
| Discovery of (S)-1-((2′,6-Bis(difluoromethyl)-[2,4′-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine (BMS-986176/LX-9211): A Highly Selective, CNS Penetrable … G Luo, L Chen, WA Kostich, B Hamman, J Allen, A Easton, C Bourin, ... Journal of Medicinal Chemistry 65 (6), 4457-4480, 2022 | 14 | 2022 |
| Discovery and optimization of biaryl alkyl ethers as a novel class of highly selective, CNS-penetrable, and orally active adaptor protein-2-associated kinase 1 (AAK1 … G Luo, L Chen, WA Kostich, B Hamman, J Allen, A Easton, C Bourin, ... Journal of Medicinal Chemistry 65 (6), 4534-4564, 2022 | 12 | 2022 |
| Preclinical evaluation of inhalational spectinamide-1599 therapy against tuberculosis M Gonzalez-Juarrero, PB Lukka, S Wagh, A Walz, J Arab, C Pearce, Z Ali, ... ACS infectious diseases 7 (10), 2850-2863, 2021 | 10 | 2021 |
| Comparative pharmacokinetics of spectinamide 1599 after subcutaneous and intrapulmonary aerosol administration in mice C Rathi, PB Lukka, S Wagh, RE Lee, AJ Lenaerts, M Braunstein, A Hickey, ... Tuberculosis 114, 119-122, 2019 | 10 | 2019 |
| Model-based exposure-response assessment for spectinamide 1810 in a mouse model of tuberculosis S Wagh, C Rathi, PB Lukka, K Parmar, Z Temrikar, J Liu, MS Scherman, ... Antimicrobial Agents and Chemotherapy 65 (11), 10.1128/aac. 01744-20, 2021 | 9 | 2021 |
| Relative quantitation of endogenous proteins by quadrupole-time of flight and tandem mass spectrometry SS Gautam, S Wagh, S Babu, R Gudihal, S Rajagopalan, P Kole, ... Journal of Chromatography B 1106, 11-18, 2019 | 4 | 2019 |
| Bioavailability testing of a newly developed clindamycin oral suspension in a pediatric porcine model GA Goode, SJ Wagh, DJ Irby, D Ma, RF Jacobs, GL Kearns, H Almoazen Pharmaceutical Development and Technology 24 (8), 1038-1043, 2019 | 3 | 2019 |
| Model-Based Dose-Exposure-Response Assessment for Lead and Backup Spectinamide in a Mouse Model of Tuberculosis SJ Wagh The University of Tennessee Health Science Center, 2020 | 1 | 2020 |
| Development of a Minimalistic Physiologically Based Pharmacokinetic (mPBPK) Model for the Preclinical Development of Spectinamide Antibiotics KR Parmar, PB Lukka, S Wagh, ZH Temrikar, J Liu, RE Lee, M Braunstein, ... Pharmaceutics 15 (6), 1759, 2023 | | 2023 |
| Translational Considerations in Developing Bispecific Antibodies: What Can We Learn from Quantitative Pharmacology? PB Lukka, S Wagh, B Meibohm Quantitative Pharmacology and Individualized Therapy Strategies in …, 2019 | | 2019 |
| PK/PD modeling of spectinamide 1599 in Mycobacterium tuberculosis infected mice S Wagh, C Rathi, PB Lukka, K Parmar, Z Temrikar, J Liu, MS Scherman, ... JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 45, S99-S99, 2018 | | 2018 |
